Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut

Benzinga_recent_news10-08

Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2573777927?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/08/Wall-Street-ai6.png?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-10-08 23:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2573777927","market":"us","top_or_hot":-1,"title":"Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut","media":"Benzinga_recent_news","content":"<div>\n<p>Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next...</p>\n\n<a href=\"https://www.benzinga.com/markets/hedge-funds/25/10/48104197/steven-cohen-doubles-the-sp-500-and-his-next-bets-all-gut\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSteven Cohen Doubles The S&P 500 — And His Next Bet's All Gut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-08 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/hedge-funds/25/10/48104197/steven-cohen-doubles-the-sp-500-and-his-next-bets-all-gut><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next...</p>\n\n<a href=\"https://www.benzinga.com/markets/hedge-funds/25/10/48104197/steven-cohen-doubles-the-sp-500-and-his-next-bets-all-gut\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.benzinga.com/markets/hedge-funds/25/10/48104197/steven-cohen-doubles-the-sp-500-and-his-next-bets-all-gut","article_id":"2573777927","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/08/Wall-Street-ai6.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/hedge-funds/25/10/48104197/steven-cohen-doubles-the-sp-500-and-his-next-bets-all-gut","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2573777927","pubTimestamp":1759937400,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Steven Cohen's Point72 Asset Management has doubled the S&P 500's three-year return and is investing in this biotech firm...","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","SDS":"两倍做空标普500 ETF-ProShares","BK4504":"桥水持仓","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","UPRO":"三倍做多标普500ETF-ProShares",".SPX":"S&P 500 Index","OEF":"标普100指数ETF-iShares","BK4007":"制药","SPXU":"三倍做空标普500ETF-ProShares","BK4585":"ETF&股票定投概念","BK4581":"高盛持仓","SH":"做空标普500-Proshares","VOO":"Vanguard标普500ETF","SSO":"2倍做多标普500ETF-ProShares","IVV":"标普500ETF-iShares","BK4534":"瑞士信贷持仓","BK4139":"生物科技","SPY":"标普500ETF","OEX":"标普100","PALI":"Palisade Bio Inc."},"translate_title":"史蒂文·科恩(Steven Cohen)将标普500翻倍——他的下一个赌注全是勇气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SDS":0.6,"UPRO":0.6,"IVV":0.6,"OEF":0.6,"ESmain":0.6,"SPXU":0.6,"SPY":1.5,"PALI":1,"VOO":1.5,"OEX":0.6,"SSO":0.6,".SPX":1.5,"SH":0.6,"MESmain":0.6},"content_text":"Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next move? A fresh swing into biotech, backing Palisade Bio Inc (NASDAQ:PALI) — a tiny, high-volatility stock working on gut-health therapies that's suddenly caught Wall Street's attention.\nThe top 20 holdings in Point72's Q2 filing have surged 131% cumulatively over the past three years, compared to just 64% for the S&P 500. That kind of outperformance puts Cohen's $42 billion hedge fund in a rare class of consistent market beaters. The firm's 18% return in the second quarter alone underscores its agility in navigating both AI euphoria and biotech resurgence.\nBut Cohen's latest trade is turning heads for another reason: size. His fund initiated a $7.6 million position in Palisade Bio, a clinical-stage biotech developing a drug to treat ulcerative colitis — a chronic intestinal condition that affects millions. It's a minuscule 0.03% slice of his portfolio, yet small bets like these have often been the early signals of Cohen's market instincts at work.\nRead Also: Steven Cohen’s Biotech Bets Are Getting Bolder — And Smaller\nPalisade Bio recently closed a $138 million public offering led by healthcare heavyweights like RA Capital, Perceptive Advisors, and Janus Henderson, to fund Phase 2 trials for its lead drug PALI-2108. \nThe stock has surged nearly 200% in the past month and another 11% in pre-market trading on Wednesday, as investors pile into the autoimmune therapy story after Cohen.\nCohen doesn't just chase trends — he spots inflection points. With Point72 delivering twice the S&P's return and now eyeing biotech names like Palisade Bio, the billionaire trader seems to be betting that the next wave of alpha may come from the gut — not just the grid.\nRead Next: \nImage created using artificial intelligence via Midjourney.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2573777927","isCrawlerRequest":true}